SANTA CLARA, Calif., October 12, 2022 - Agilent Technologies Inc. (NYSE: A) today announced the opening of the Dissolution Center of Excellence (CoE) facility in Craven Arms, United Kingdom. The newly modernized premises will house the core of Agilent’s dissolution business, including research and development, quality, support, applications, marketing, and more. This investment allows all Agilent dissolution activities to be consolidated under one roof, facilitating the cooperation of all business segments and driving the mission of innovation for the next generation of dissolution products and services.

Agilent Technologies Inc. (NYSE: A) is proud to announce the release of its latest innovation in dissolution testing, the Dissolution Workflow Manager for OpenLab CDS. This cutting- edge software solution is designed to streamline and enhance dissolution testing workflows, providing improved efficiency and accuracy for pharmaceutical and biopharmaceutical laboratories.

The Dissolution Workflow Manager offers a comprehensive suite of features that simplify the dissolution testing process, from automated dosage delivery to sampling and reporting. Key highlights include:

• Seamless Integration with OpenLab CDS: The Dissolution Workflow Manager is fully integrated with Agilent's OpenLab Chromatography Data System (CDS), enabling users to manage their dissolution testing data within a single, unified platform. This integration ensures data integrity, compliance, and ease of use.
• Real-Time Monitoring on Your Terms: With real-time monitoring capabilities based on customized user profiles, the Dissolution Workflow Manager allows users to track the progress of their dissolution tests for all 708-DS and 850-DS dissolution systems within an environment that meets your organization’s standards.
• Enhanced Compliance and Data Integrity: The Dissolution Workflow Manager is designed to meet the stringent regulatory requirements of the pharmaceutical industry. The software includes features such as audit trails, electronic signatures, and secure data storage to ensure compliance with 21 CFR Part 11 and other regulatory standards.
• User-Friendly Interface: The intuitive, user-friendly, OpenLab-based interface of the Dissolution Workflow Manager makes it easy for users of all experience levels to navigate and operate the software. Comprehensive training and support resources are also available to help users get the most out of their investment.

This innovative software solution represents a significant advancement in dissolution testing, providing dissolution laboratories with the integrated tools they need to achieve greater efficiency and compliance on a platform deeply rooted in the pharmaceutical industry.

For more information about the Dissolution Workflow Manager and OpenLab CDS, please visit www.agilent.com/en/ product/dissolution-testing/dissolution-software/dissolution-workflow-manager-openlab-cds or contact your Agilent representative.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com.